ロード中...
MRD in AML: does it already guide therapy decision-making?
Prognostic factors determined at diagnosis are predictive for outcome whereas achievement of morphological complete remission (CR) is still an important end point during treatment. Residual disease after therapy may reflect the sum of all diagnosis and postdiagnosis resistance mechanisms/factors; it...
保存先:
| 出版年: | Hematology Am Soc Hematol Educ Program |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142473/ https://ncbi.nlm.nih.gov/pubmed/27913502 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|